Breaking through R&D IT Bottlenecks for Structural Biologists
Value Delivered
Accelerated Drug Discovery Throughput
Enhanced Collaboration & Productivity
Scalable, Future-Ready Cloud Infrastructure
Cryo-Electron Microscopy (Cryo-EM) is reshaping the landscape of structure-based drug design (SBDD)—but only when organizations can support the scale and complexity it demands. A leading top 20 biopharma faced precisely this challenge: massive datasets, fragmented tools, and limited compute resources were slowing discovery and hindering collaboration.
That’s where Clovertex stepped in.
By implementing its Numen™ cloud-based scientific discovery platform on a secure AWS environment, Clovertex enabled the biopharma’s scientists to run complex Cryo-EM workflows at scale without the previous IT and infrastructure bottlenecks.
The result? Faster structural biology insights, streamlined collaboration, and reduced costs.
Key outcomes included:
- Scalable compute for high-performance Cryo-EM
- Seamless integration of tools like CryoSPARC, Relion, and SBGRID Suite of Apps
- Real-time data access and cross-functional collaboration
- Significant reductions in R&D overhead
Want to see the full transformation?
Download the full case study (PDF) to learn how this global biopharma unlocked the full potential of Cryo-EM and modernized its drug discovery pipeline.
